Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells

National Medical Journal of China

Volumn 85, Issue 12, 2005, Pages 825-830

  Liu, Xiao Hong ^a   Lin, Jing ^b   Cao, Xiao Zhe ^b   Zheng, Jian Ming ^b   Chen, Ying ^b   Zhu, Ming Hua ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Carcinoma, hepatocellular; Hepatitis B virus; Recombination, genetic

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; HEPATITIS B VIRUS X PROTEIN; MUTANT PROTEIN; PLASMID DNA; PROTEIN P53;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER SIZE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE DELETION; GENE FUNCTION; GENETIC TRANSFECTION; GROWTH CURVE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE STRAIN; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; GENE DELETION; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, PROTEIN; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 16844375851     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Birrer RB, Birrer D, Klavins JV. Hepatocellular carcinoma and hepatitis virus. Ann Clin Lab Sci, 2003, 33:39-54.
2. Tu H, Bonura, C, Giannini C, et al. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res, 2001, 61: 7803-7810.
3. Sirma H, Giannini C, Poussin K, et al. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene, 1999, 18:4848-4859.
4. Iavarone M, Trabut JB, Delpuech O, et al. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol, 2003, 39: 253-261.
5. Murakami S, Cheong JH, Kaneko S. Human hepatitis B virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem, 1994,269:15118-15123.
6. Elmore LW, Hancock AR, Chang SF, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A, 1997, 94:14707-14712.
7. Feitelson MA, Clayton MM. X antigen/antibody markers in hepadnavirus infections. Antibodies to the X gene product (s). Gastroenterology, 1990, 99: 500-507.
8. Lin J, Zhu MH, Zhu Z, et al. The role of hepatitis B virus X gene and p53 on hepatocellular carcinoma cell growth. Chin J Pathol, 2003, 32:43-47.
9. Lin J, Zhu MH, Qu JH, et al. Effects of hepatitis B virus X gene on p21WAF1 expression through p53-dependent and p53-independent pathways. Chin J Cancer, 2004,23:749-755.
10. Zhu Z, Zhu MH, Ni CR. Significance of p33ING1b and p53 gene expression in hepatocellular carcinoma. Natl Med J China, 2002, 82,1332-1336.
11. Shih WL, Kuo ML, Chuang SE, et al. Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem, 2000, 275: 25858-25864.
12. Schuster R, Gerlich WH, Schaefer S. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene, 2000, 19:1173-1180.
13. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem, 1998, 273:381-385.